PHARMACEUTICAL COMPOSITION

摘要

AbstractThe present invention is directed to provide infection inhibitor products for an influenza virus. More specifically, an inhibitory substance that inhibits the activity of an RR sequence to permit a molecule of which it forms a part to be introduced into cells, such as an antibody that recognizes a peptide having an amino acid sequence RERRRKKR (SEQ ID NO. 1), is formulated as a pharmaceutical composition and an infection inhibitor products for an influenza virus containing the pharmaceutical composition is manufactured.